Упрощенная HTML-версия
406.
Roel G. P. Quality of life with treatment of hypertension / G. P. Roel, C. L.
Hildebrant, R. H. Grimm // Curr Hypertens Rep. – 2001. – Vol. 3, № 6. – Р. 466-
472.
407.
Role of sympathoadrenal 1-medullary activation in the initiation and
progression of atherosclerosis / J. R. Kaplan [et al.] // Circulation. – 1991. –
Vol. 84 (Suppl. 6). – P. 123-132.
408.
Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome / R.
Rosmond // Psychoneuroendocrinology. – 2005. – № 30. – Р. 1-10.
409.
Population-based examination of the interaction of primary
hypertension and obesity in South Carolina / A.
Am. J.
Hypertens. – 2007. – Vol. 20, № 1. – Р. 6-10.
410.
Sampanis C. Arterial hypertension in diabetes mellitus: from theory to clinical
practice / C. Sampanis, C. Zamboulis // Hippokratia. – 2008. – Vol. 12, № 2. –
P. 74 – 80.
411.
Schmeiser-Rieder A. Blood pressure awareness in Austria. A 20-year
evaluation, 1978-1998 / A. Schmeiser-Rieder, U. Kunze // Eur. Heart J. – 2000.
– Vol. 21, № 5. – P. 414-420.
412.
Schmidtke K. Cerebral small vessel diseases: how does it progress? / K.
Schmidtke, M. Hull // J. Neurol. Sc. – 2005. – V. 229. – Р. 13-20.
413.
Selective imidazoline receptor agonists and lipid metabolism / M. S. Elisaf [et
al.] // Clin Chem Lab Med. – 1999. – Vol. 37. – P. 165.
414.
Selective inhibition by probucol of vascular cell adhesion molecule-1 (VCAM-
1) expression in human vascular endothelial cell / D. Zapolska-Downar [et al.]
// Atherosclerosis. – 2001. – Vol. 155, № 1. – P. 123-130.
415.
Selye H. Perspectives in Stress / H. Selye // Research. Perspectives in Biol. and
Med. – 1959. – Vol. II, № 4. – Р. 403.
416.
Semenkovich C. F. Insulin resistance and atherosclerosis / C. F. Semenkovich
// J. Clin. Invest. – 2006. – Vol. 116, № 7. – P. 1813–1822.